A study of flupenthixol decanoate and pipotiazine undecylenate in schizophrenics.
D014150:Antipsychotic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003299:Cooperative Behavior; D003692:Delayed-Action Preparations; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D010640:Phenothiazines; D010879:Piperazines / Q000009:adverse effects / Q000627:therapeutic use; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*; D013449:Sulfonamides / Q000009:adverse effects / Q000627:therapeutic use; D013892:Thioxanthenes / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000627:therapeutic use*
D014150:Antipsychotic Agents; D003692:Delayed-Action Preparations; D010640:Phenothiazines; D010879:Piperazines; D010880:Piperidines; D013449:Sulfonamides; D013892:Thioxanthenes; D014149:Tranquilizing Agents